Recent evidence suggests that Ouabain can inhibit the secretion of pro-inflammatory cytokines, such as tumor necrosis factor-alpha (TNF-α) and interleukin-6 (IL-6), in macrophages, thereby mitigating inflammatory responses in conditions like rheumatoid arthritis and multiple sclerosis. Here, IL6 is linked to multiple sclerosis.